Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COVID-19: The question of genetic diversity and therapeutic intervention approaches. | Genet Mol Biol | 2021 | 35421211 | PubTator, text mining | PubMed |
| Nature's therapy for COVID-19: Targeting the vital non-structural proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants. | Phytomed Plus | 2021 | 35403083 | PubTator, text mining | PubMed |
| Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro. | Front Pharmacol | 2021 | 35401158 | PubTator, text mining | PubMed |
| Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic. | Phytomed Plus | 2021 | 35399819 | PubTator, text mining | PubMed |
| The Interplay Between Coronavirus and Type I IFN Response. | Front Microbiol | 2021 | 35317429 | PubTator, text mining | PubMed |
| Cytomorphic Electronic Systems: A review and perspective. | IEEE Nanotechnol Mag | 2021 | 35242267 | PubTator, text mining | PubMed |
| Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma. | Front Genet | 2021 | 35222516 | PubTator, text mining | PubMed |
| Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development. | Front Chem | 2021 | 35186898 | PubTator, text mining | PubMed |
| Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets. | mBio | 2021 | 35164548 | PubTator, text mining | PubMed |
| Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification. | Front Oncol | 2021 | 35155211 | PubTator, text mining | PubMed |
| Analysis of N6-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction. | Front Genet | 2021 | 35140740 | PubTator, text mining | PubMed |
| Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies. | Front Immunol | 2021 | 35140714 | PubTator, text mining | PubMed |
| SARS-COV-2 Variants: Differences and Potential of Immune Evasion. | Front Cell Infect Microbiol | 2021 | 35118007 | PubTator, text mining | PubMed |
| An Updated Review of Porcine Deltacoronavirus in Terms of Prevalence, Pathogenicity, Pathogenesis and Antiviral Strategy. | Front Vet Sci | 2021 | 35097055 | PubTator, text mining | PubMed |
| Multi-Targeted Approaches and Drug Repurposing Reveal Possible SARS-CoV-2 Inhibitors. | Vaccines (Basel) | 2021 | 35062685 | PubTator, text mining | PubMed |
| Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid. | Front Pharmacol | 2021 | 35002708 | PubTator, text mining | PubMed |
| Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry. | Front Immunol | 2021 | 34975904 | PubTator, text mining | PubMed |
| Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges. | PLoS Pathog | 2021 | 34969061 | PubTator, text mining | PubMed |
| Coronavirus RNA Synthesis Takes Place within Membrane-Bound Sites. | Viruses | 2021 | 34960809 | PubTator, text mining | PubMed |
| Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike. | Viruses | 2021 | 34960703 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=66